Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Penumbra IncPEN · Entity 3430 | Director | February 13, 2026 | February 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Penumbra Inc
Report date February 13, 2026 · Filed February 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,962 |
Reported balance
After 2026-02-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-13 · Grant · Acquired 589 · Balance 5,962 F1: Restricted stock units (RSUs) vest as to 1/4 on each of March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to Ms. O'Rourke's continued service as director through such dates. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to Ms. O'Rourke's continued service as director through such date. F2: A portion of these shares is subject to vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units (RSUs) vest as to 1/4 on each of March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, subject to Ms. O'Rourke's continued service as director through such dates. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation, a Delaware corporation, and Pinehurst Merger Sub, Inc., a Delaware corporation) occurs, any of the RSUs that remain unvested will fully vest on the Closing, subject to Ms. O'Rourke's continued service as director through such date.
F2: A portion of these shares is subject to vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 21, 2017 Filed Nov 21, 2017 22:46 UTC | Penumbra Inc PEN · Entity 3430 | SaleCommon Stock | 429 | $106.60 | $45,731.40 |
DisclosureSEC source: 0001321732-17-000181 · wf-form4_151130434888766.xml · nonDerivative · entry 1 O'Rourke Bridget · CIK 0001704713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,935 F1 · balance_after: A portion of these shares is subject to vesting. Read SEC document |
| April 21, 2017 Filed Apr 26, 2017 00:23 UTC | Penumbra Inc PEN · Entity 3430 | GrantCommon Stock | 827 | $0.00 | $0.00 |
DisclosureSEC source: 0001321732-17-000109 · wf-form4_149316620336527.xml · nonDerivative · entry 2 O'Rourke Bridget · CIK 0001704713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,245 F2 · security: Restricted stock units vest as to approximately 1/3 on each of June 30, 2017, September 30, 2017 and December 31, 2017, subject to Ms. O'Rourke's continued service as a director through such dates. Read SEC document |
| April 21, 2017 Filed Apr 26, 2017 00:23 UTC | Penumbra Inc PEN · Entity 3430 | GrantCommon Stock | 1,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001321732-17-000109 · wf-form4_149316620336527.xml · nonDerivative · entry 1 O'Rourke Bridget · CIK 0001704713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,418 F1 · security: Restricted stock units vest as to 1/16 in approximately equal quarterly installments on the last day of each calendar quarter starting with the calendar quarter ending June 30, 2017, subject to Ms. O'Rourke's continued service as a director through such dates. Read SEC document |
| April 21, 2017 Filed Jul 25, 2017 23:16 UTC Amendment | Penumbra Inc PEN · Entity 3430 | GrantCommon Stock | 946 | $0.00 | $0.00 |
DisclosureSEC source: 0001321732-17-000136 · wf-form4a_150102458236403.xml · nonDerivative · entry 2 O'Rourke Bridget · CIK 0001704713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,364 F2 · security: Restricted stock units vest as to approximately 1/3 on each of June 30, 2017, September 30, 2017 and December 31, 2017, subject to Ms. O'Rourke's continued service as a director through such dates. F3 · shares: The original Form 4 filed on April 25th inadvertently understated the number of RSUs granted to the Reporting Person by 119. This amendment to the Form 4 is being filed solely to correct the error and reflect the total number of RSUs underlying the award. F3 · balance_after: The original Form 4 filed on April 25th inadvertently understated the number of RSUs granted to the Reporting Person by 119. This amendment to the Form 4 is being filed solely to correct the error and reflect the total number of RSUs underlying the award. Read SEC document |
| April 21, 2017 Filed Jul 25, 2017 23:16 UTC Amendment | Penumbra Inc PEN · Entity 3430 | GrantCommon Stock | 1,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001321732-17-000136 · wf-form4a_150102458236403.xml · nonDerivative · entry 1 O'Rourke Bridget · CIK 0001704713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,418 F1 · security: Restricted stock units vest as to 1/16 in approximately equal quarterly installments on the last day of each calendar quarter starting with the calendar quarter ending June 30, 2017, subject to Ms. O'Rourke's continued service as a director through such dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.